Trace Aldehydes in Solid Oral Dosage Forms as Catalysts for Nitrosating Secondary Amines.

Area of Science:

• Pharmaceutical Chemistry
• Drug Stability
• Impurity Profiling

Background:

• Nitrosamine impurities are a concern in pharmaceutical manufacturing.
• Traditional nitrosamine formation mechanisms involve nitrous acid at low pH (≤5).
• Formaldehyde's catalytic role in nitrosamine formation at higher pH (∼6+) is established in solution.

Purpose of the Study:

• To highlight formaldehyde as a potential catalyst for nitrosamine formation in oral drug products.
• To extend the understanding of formaldehyde-catalyzed nitrosation from solution to solid-state pharmaceutical forms.
• To explain nitrosamine impurity growth observed during long-term stability studies.

Main Methods:

• Review of existing solution-phase chemistry regarding formaldehyde, secondary amines, and nitrite.
• Analysis of pharmaceutical solid dosage forms and stability data.
• Correlation of observed nitrosamine levels with potential formaldehyde-catalyzed pathways.

Main Results:

• Formaldehyde, a common excipient, can catalyze nitrosamine formation with secondary amines and nitrite ions.
• This catalytic mechanism is effective at neutral to alkaline pH (∼6 and higher), unlike traditional pathways.
• The formaldehyde-catalyzed pathway is relevant to nitrosamine growth in solid oral dosage forms, as evidenced by product recalls.

Conclusions:

• Pharmaceutical scientists must consider formaldehyde-catalyzed nitrosation as a significant mechanism for nitrosamine impurity formation in oral drug products.
• This pathway provides a plausible explanation for nitrosamine growth during stability studies, particularly at pH values above 5.
• Understanding this mechanism is crucial for preventing nitrosamine contamination and ensuring drug product safety.